. 2022 Nov 24;38(3):489–502. doi: 10.1093/humrep/deac249

Table IV.

Female fertility preservation for cancer or haematopoietic stem cells transplantation.

	Embryo cryopreservation	Oocyte vitrification	Ovarian tissue cryopreservation
LBR after IVF	41 (34–48, I²: 0%)^*	32 (26–39, I²: 0%)^*	19 (15–24, I²: 18.5%)^*
Women with at least one live birth after IVF	43 (36–50, I²: 0%)^*	32 (25–39, I²: 0%)^*	17 (13–22, I²: 0%)^*
Miscarriage	22 (14–30, I²: 0%)^*	11 (6–19, I²: 0%)^*	14 (9–21, I²: 33%)^**
Spontaneous LBR			33 (25–42, I²: 46.1%)^**
Women with at least one spontaneous live birth			32 (23–41, I²: 51%)^**

Live birth rate (LBR as %) and percentage of miscarriage estimated for each fertility preservation method.

Percentage of events with two-sided CI estimated over all the publications; heterogeneity = I².

Fixed effect model.

^**

Random effect model.